Business
CytoSorbents Announces Virtual Annual Meeting
MONMOUTH JUNCTION, N.J., May 27, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its
About this update from Cytosorbents Corporation
[{"type":"text","content":"MONMOUTH JUNCTION, N.J., May 27, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, will host its Virtual Annual Meeting on Tuesday, June 2, 2020 at 10:00 AM EDT. Stockholders of record will be able to virtually join and submit questions, and those that have not yet voted will be able to vote their shares electronically at the meeting. \n\n \n \n \n \n \n \n\n \nTo participate in the Virtual Annual Meeting, stockholders will need the 16-digit control number included on the \"Important Notice Regarding the Availability of Proxy Materials\" proxy card or voting instruction form. If you join through your brokerage firm's website and do not have your control number, you can gain access to the meeting by logging into your brokerage firm's website 30 minutes prior to the meeting start, selecting the shareholder communications mailbox to link through to the meeting, and the control number will automatically populate. \nThe Annual Meeting webcast will begin promptly at 10:00 AM Eastern Time. We encourage stockholders to access the Annual Meeting 30 minutes prior to the start time, to allow ample time for the check-in procedures. Technicians will be ready to assist with any technical difficulties you may have accessing the virtual Annual Meeting. A phone number where you can obtain technical assistance will be made available on the Stockholder Meeting Link 30 minutes prior to the Annual Meeting.\nAnnual Meeting Details:\nDate: \nTuesday, June 2, 2020\nTime: \n10:00 AM EDT\nStockholder Meeting Link: \nwww.virtualshareholdermeeting.com/CTSO2020 \nAbout CytoSorbents Corporation (NASDAQ: CTSO)\nCytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the \"cytokine storm\" or \"cytokine release syndrome\" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. C...